Riskpilot← Back to searchSign inGet full accessDeepMed AB
ABActiveOrg 5590485909Dalagatan 78 AHospital activities · NACE 8610Est. 20160 employees
Revenue 2025
SEK 150K
+409% vs 2024
EBITDA margin
82.1%
+335% vs 2024
Equity ratio
58.2%
Financial strength
Net profit 2025
SEK 109K
+308% vs 2024
| Revenue | SEK 150K | +409% |
| EBITDA | SEK 123K | +335% |
| Net profit | SEK 109K | +308% |
| Total assets | SEK 177K | +252% |
| Equity | SEK 103K | +1960% |
| Employees | 0 | — |
Legal name
DeepMed AB
Org number
5590485909
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
25 januari 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Datavetenskap, artificiell intelligens, konsulttjänster inom hälsa och sjukvård samt därmed förenlig verksamhet.
Address
Dalagatan 78 A
Email
max@gforge.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 62 | 0 | 0 | 30 | 150 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 44 | −20 | −21 | −52 | 123 |
| Depreciation & amort. | −0 | — | −0 | — | — |
| EBIT | 44 | −20 | −21 | −52 | 123 |
| Net financials | — | — | — | 0 | 0 |
| Profit before tax | 33 | −9 | −21 | −52 | 123 |
| Tax | −7 | — | −0 | — | −15 |
| Net profit | 26 | −9 | −21 | −52 | 109 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 119 | 89 | 74 | 50 | 177 |
| Equity | 77 | 42 | 20 | −6 | 103 |
| Long-term debt | 0 | — | 6 | 6 | 0 |
| Short-term debt | 31 | 48 | 48 | 50 | 74 |
| Total debt | 31 | 48 | 54 | 56 | 74 |
EBITDA margin
82.1%
This company
15.8%
Market median
+420% vs market
20212025
Equity ratio
58.2%
This company
38.2%
Market median
+52% vs market
20212025
Return on equity
105.4%
This company
18.4%
Market median
+473% vs market
20212025
Net profit margin
72.4%
This company
8.1%
Market median
+794% vs market
20212025
Asset turnover
0.85×
This company
1.12×
Market median
+24% vs market
20212025
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-06-01 – 2022-05-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-06-01 – 2021-05-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (3) | ||
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DeepMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christer Anthony Jilert | Board of Directors | 0 companies |
| Andreas Wilhelm Helge Stark | Board of Directors | 0 companies |
| Max Gordon | Chairman | 0 companies |
| Christopher Krzysztof Gordon | Deputy Board Member | 0 companies |
| Ulla Daniela Gordon | Board of Directors | 0 companies |
| Olof Gustaf Sköldenberg | Board of Directors | 0 companies |